Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Differential modulation of N-type calcium channels by micro-opioid receptors in oxytocinergic versus vasopressinergic neurohypophysial terminals.

Opioids modulate the electrical activity of magnocellular neurons (MCN) and inhibit neuropeptide release at their terminals in the neurohypophysis. We have previously shown that micro-opioid receptor (MOR) activation induces a stronger inhibition of oxytocin (OT) than vasopressin (AVP) release from isolated MCN terminals. This higher sensitivity of OT release is due, at least in part, to the selective targeting of R-type calcium channels. We now describe the underlying basis for AVP's weaker inhibition by MOR activation and provide a more complete explanation of the complicated effects on neuropeptide release. We found that N-type calcium channels in AVP terminals are differentially modulated by MOR; enhanced at lower concentrations but increasingly inhibited at higher concentrations of agonists. On the other hand, N-type calcium channels in OT terminals were always inhibited. The response pattern in co-labeled terminals was analogous to that observed in AVP-containing terminals. Changes in intracellular calcium concentration and neuropeptide release corroborated these results as they showed a similar pattern of enhancement and inhibition in AVP terminals contrasting with solely inhibitory responses in OT terminals to MOR agonists. We established that fast translocation of Ca(2+) channels to the plasma membrane was not mediating current increments and thus, changes in channel kinetic properties are most likely involved. Finally, we reveal a distinct Ca-channel beta-subunit expression between each type of nerve endings that could explain some of the differences in responses to MOR activation. These results help advance our understanding of the complex modulatory mechanisms utilized by MORs in regulating presynaptic neuropeptide release.

Pubmed ID: 20509142 RIS Download

Mesh terms: Analgesics, Opioid | Animals | Arginine Vasopressin | Calcium | Calcium Channels, N-Type | Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | Male | Oxytocin | Patch-Clamp Techniques | Pituitary Gland, Posterior | Rats | Rats, Sprague-Dawley | Receptors, Opioid, mu | Synapses | Synaptic Transmission

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NINDS NIH HHS, Id: R01 NS029470
  • Agency: NIAAA NIH HHS, Id: R01 AA008003-22
  • Agency: NIAAA NIH HHS, Id: AA08003
  • Agency: NIDA NIH HHS, Id: DA10487
  • Agency: NIDA NIH HHS, Id: R01 DA010487
  • Agency: NIDA NIH HHS, Id: R01 DA010487-05
  • Agency: NIAAA NIH HHS, Id: R01 AA008003
  • Agency: NINDS NIH HHS, Id: NS24970

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Cavbeta4 calcium channel antibody

Cavbeta4 calcium channel NULL

antibody

View all literature mentions

Cavbeta4 calcium channel antibody

Cavbeta4 calcium channel NULL

antibody

View all literature mentions